rs149344982

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 4P and 20B. PM1PM5BP4_StrongBP6_Very_StrongBS1BS2

The NM_000478.6(ALPL):​c.455G>A​(p.Arg152His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0128 in 1,612,314 control chromosomes in the GnomAD database, including 226 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R152C) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.0090 ( 13 hom., cov: 33)
Exomes 𝑓: 0.013 ( 213 hom. )

Consequence

ALPL
NM_000478.6 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:20O:1

Conservation

PhyloP100: 0.283
Variant links:
Genes affected
ALPL (HGNC:438): (alkaline phosphatase, biomineralization associated) This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_000478.6
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-21563266-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1470828.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=3, Uncertain_significance=2}.
BP4
Computational evidence support a benign effect (MetaRNN=0.006093651).
BP6
Variant 1-21563267-G-A is Benign according to our data. Variant chr1-21563267-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 197679.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-21563267-G-A is described in Lovd as [Pathogenic]. Variant chr1-21563267-G-A is described in Lovd as [Benign]. Variant chr1-21563267-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00896 (1361/151928) while in subpopulation SAS AF= 0.032 (154/4808). AF 95% confidence interval is 0.0279. There are 13 homozygotes in gnomad4. There are 677 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALPLNM_000478.6 linkc.455G>A p.Arg152His missense_variant Exon 5 of 12 ENST00000374840.8 NP_000469.3 P05186-1A0A024RAB4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALPLENST00000374840.8 linkc.455G>A p.Arg152His missense_variant Exon 5 of 12 1 NM_000478.6 ENSP00000363973.3 P05186-1

Frequencies

GnomAD3 genomes
AF:
0.00898
AC:
1364
AN:
151810
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00261
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00742
Gnomad ASJ
AF:
0.00982
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0326
Gnomad FIN
AF:
0.00680
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0124
Gnomad OTH
AF:
0.0134
GnomAD3 exomes
AF:
0.0115
AC:
2872
AN:
249266
Hom.:
44
AF XY:
0.0133
AC XY:
1793
AN XY:
134942
show subpopulations
Gnomad AFR exome
AF:
0.00155
Gnomad AMR exome
AF:
0.00629
Gnomad ASJ exome
AF:
0.00752
Gnomad EAS exome
AF:
0.000272
Gnomad SAS exome
AF:
0.0293
Gnomad FIN exome
AF:
0.00788
Gnomad NFE exome
AF:
0.0126
Gnomad OTH exome
AF:
0.0122
GnomAD4 exome
AF:
0.0132
AC:
19300
AN:
1460386
Hom.:
213
Cov.:
37
AF XY:
0.0138
AC XY:
10023
AN XY:
726352
show subpopulations
Gnomad4 AFR exome
AF:
0.00212
Gnomad4 AMR exome
AF:
0.00676
Gnomad4 ASJ exome
AF:
0.00752
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.0302
Gnomad4 FIN exome
AF:
0.00772
Gnomad4 NFE exome
AF:
0.0132
Gnomad4 OTH exome
AF:
0.0151
GnomAD4 genome
AF:
0.00896
AC:
1361
AN:
151928
Hom.:
13
Cov.:
33
AF XY:
0.00912
AC XY:
677
AN XY:
74260
show subpopulations
Gnomad4 AFR
AF:
0.00260
Gnomad4 AMR
AF:
0.00741
Gnomad4 ASJ
AF:
0.00982
Gnomad4 EAS
AF:
0.000772
Gnomad4 SAS
AF:
0.0320
Gnomad4 FIN
AF:
0.00680
Gnomad4 NFE
AF:
0.0124
Gnomad4 OTH
AF:
0.0133
Alfa
AF:
0.0108
Hom.:
7
Bravo
AF:
0.00791
TwinsUK
AF:
0.00890
AC:
33
ALSPAC
AF:
0.0117
AC:
45
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.0144
AC:
124
ExAC
AF:
0.0112
AC:
1363
Asia WGS
AF:
0.0120
AC:
40
AN:
3478
EpiCase
AF:
0.0165
EpiControl
AF:
0.0170

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:20Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
Oct 19, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 32160374, 31793067, 28492530, 27884173, 21228398, 11438998, 22995991, 21956185, 25023282) -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ALPL: PM5, BP4, BS1, BS2 -

Aug 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Dec 09, 2014
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not specified Benign:5
Mar 12, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 14, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, gene and variant associated with hypophosphatasia -

-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hypophosphatasia Benign:3Other:1
-
GeneReviews
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

Feb 27, 2025
JKU Lab, Dept of Paediatrics, Johannes Kepler University
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is present in GnomAD 4.1 (f = 0.01281) and affects no functional domain. The variant is not predicted to affect protein function (REVEL score: 0.2619). Splice-prediction algorithms predict no effect on splicing. In vitro functional studies were not required. This variant has been reported in the literature in individuals affected with ALPL-related conditions. The applied ACMG criteria can be viewed at: https://alplmutationdatabase.jku.at/table/ -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Osteogenesis imperfecta Benign:1
Dec 18, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Childhood hypophosphatasia;C0268412:Infantile hypophosphatasia;C0268413:Adult hypophosphatasia Benign:1
Jul 07, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Infantile hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Adult hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Childhood hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Uncertain
0.61
D;.;.;D
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.30
N
LIST_S2
Benign
0.68
.;T;T;T
MetaRNN
Benign
0.0061
T;T;T;T
MetaSVM
Uncertain
-0.26
T
MutationAssessor
Benign
0.81
L;.;.;L
PrimateAI
Benign
0.28
T
PROVEAN
Benign
1.4
N;N;N;N
REVEL
Benign
0.26
Sift
Benign
0.43
T;T;T;T
Sift4G
Benign
0.23
T;T;T;T
Polyphen
0.072
B;.;.;B
Vest4
0.063
MPC
0.56
ClinPred
0.011
T
GERP RS
2.6
Varity_R
0.039
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149344982; hg19: chr1-21889760; API